Agilent Technologies, Inc. $A Shares Sold by Valeo Financial Advisors LLC

Valeo Financial Advisors LLC lessened its position in Agilent Technologies, Inc. (NYSE:A) by 22.5% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 2,673 shares of the medical research company’s stock after selling 776 shares during the period. Valeo Financial Advisors LLC’s holdings in Agilent Technologies were worth $315,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Stone House Investment Management LLC acquired a new position in shares of Agilent Technologies in the first quarter valued at approximately $30,000. Opal Wealth Advisors LLC acquired a new position in Agilent Technologies during the first quarter worth approximately $31,000. Ransom Advisory Ltd acquired a new position in Agilent Technologies during the first quarter worth approximately $32,000. Central Pacific Bank Trust Division acquired a new position in Agilent Technologies during the second quarter worth approximately $33,000. Finally, Zions Bancorporation National Association UT acquired a new position in Agilent Technologies during the first quarter worth approximately $38,000.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the stock. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Agilent Technologies in a research report on Wednesday. Wells Fargo & Company upped their price target on shares of Agilent Technologies from $140.00 to $150.00 and gave the stock an “overweight” rating in a research report on Monday, September 15th. JPMorgan Chase & Co. upped their price target on shares of Agilent Technologies from $155.00 to $165.00 and gave the stock an “overweight” rating in a research report on Thursday. Rothschild & Co Redburn assumed coverage on shares of Agilent Technologies in a research report on Wednesday. They set a “buy” rating and a $165.00 price target for the company. Finally, Rothschild Redb raised shares of Agilent Technologies to a “strong-buy” rating in a research report on Wednesday. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $148.69.

Agilent Technologies Price Performance

A opened at $140.13 on Friday. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $153.84. The company has a 50 day moving average of $124.58 and a two-hundred day moving average of $116.94. The company has a market cap of $39.73 billion, a P/E ratio of 32.89, a P/E/G ratio of 4.60 and a beta of 1.26.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, meeting the consensus estimate of $1.37. The business had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The business’s quarterly revenue was up 10.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be paid a $0.248 dividend. The ex-dividend date is Tuesday, September 30th. This represents a $0.99 annualized dividend and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio is 23.24%.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.